SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Izzy who wrote (3002)11/26/1997 10:02:00 AM
From: Oliver & Co  Respond to of 6136
 
No, genotypic and phenotypic comercial testing is still too early, the companies that make these tests are making too many unsubstantiated claims. We still don't have enough data to use these tests in clinical practice. I agree with Dr. Mellors when he says that all these tests are research tools so far. I am not into research, but into clinical practice.

JLL